Navigation Links
Who gives stem cells their marching orders?

Researchers from the Swiss Institute for Experimental Cancer Research (ISREC) have shown that a single gene involved in embryonic development is responsible for two seemingly contradictory activities -- maintaining stem cells after the embryo has implanted in the mother's uterus, and later providing cues to direct their differentiation in a coordinated fashion when the time is ripe.

The development of an embryo from a few seemingly identical stem cells is a truly awesome feat of nature. As they bathe in a chemical soup they've manufactured themselves, stem cells react to subtle changes in chemical concentration, moving apart and taking on distinct identities. The million-dollar question: How do these cells ?all initially the same, and exposed to the same environment ?end up acting in such different ways, and in so orchestrated a manner? Understanding the choreography involved in this mysterious cellular signaling dance is crucial to our ability to coax stem cells to grow into specific tissues outside the body. And it is also important if we are to understand and perhaps correct what goes wrong when the chemical signaling system goes awry and stem cells become cancerous.

Research has shown that the chemical soup in the developing embryo contains a protein factor called Nodal, a powerful "master chef" that controls the activity of a whole host of important regulatory genes. The ISREC group showed that embryos already need Nodal when they attach to the wall of the uterus, to expand their pool of stem cells, and to let individual cells know where they are with respect to their neighbors. However, to carry out these tasks, the Nodal protein must be cleaved by specific enzymes. The enzymes act as a sort of regulatory switch, increasing the stem cells' production of Nodal and preventing them from differentiating too early. Using mice engineered to carry an altered form of the protein, the ISREC group showed that if this switch is blocked, Nodal has the opp osite effect: it triggers a cascade of molecular signals which stimulate differentiation.

In an article appearing in the September issue of the journal Developmental Cell, the researchers explain how cleaved and uncleaved forms of the Nodal protein act together to let the stem cells know where to move and what to become, once the embryo has reached a critical size. "Whole blocks of chemical "programs" are triggered in a cascading fashion, with Nodal there to maintain the source of a concentration gradient," explains EPFL (Ecole Polytechnique Fédérale de Lausanne) professor Daniel Constam, lead researcher on the project. Constam adds that cells respond differently depending on the amount of time they have been exposed to the Nodal signal.

One hallmark of aggressive cancer cells is their unspecified nature, similar to that of embryonic stem cells. Constam and his colleagues think that the signaling pathways used by tumor cells to migrate and invade new territory might be similar to those used in the embryonic development of the organism. Recent research from Northwestern University seems to confirm this, showing that aggressive melanoma cells secrete the Nodal protein. Understanding the activity of this gene in embryonic development may hold the key to finding a way to control its activity in tumor cells. "We need to separate the aspects of Nodal function, and how this protein is regulated by the cell at the molecular level," says Constam. "The embryo holds the key to this understanding."
'"/>

Source:Ecole Polytechnique F茅d茅rale de Lausanne


Related biology news :

1. New imaging method gives early indication if brain cancer therapy is effective, U-M study shows
2. A little stress gives beneficial oomph! to immune system
3. Bionic arm gives amputee sense of touch
4. Gene thwarts some pathogens, gives access to others, could save crops
5. US woman gives birth to baby from worlds first frozen donor egg bank
6. Researcher gives hard thoughts on soft inheritance
7. Unique gene regulation gives chilly bugs survival advantage at bottom of the world
8. Thymus transplants gives hope to babies with fatal immune disease
9. Wisconsin scientists grow critical nerve cells
10. Spleen may be source of versatile stem cells
11. Researchers discover way to make cells in the eye sensitive to light

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:7/20/2017)... , July 20, 2017 Delta (NYSE: DAL ) ... any Delta aircraft at Reagan Washington National Airport (DCA). ... Delta launches biometrics to board ... Delta,s biometric boarding ... Club is now integrated into the boarding process to allow eligible ...
(Date:5/23/2017)... -- Hunova, the first robotic gym for the rehabilitation and functional motor sense ... Genoa, Italy . The first 30 robots will be available ... USA . The technology was developed and patented at the IIT ... Movendo Technology thanks to a 10 million euro investment from entrepreneur Sergio ... ...
(Date:4/24/2017)... WASHINGTON , April 24, 2017 ... counsel and partner with  Identity Strategy Partners, LLP ... "With or without President Trump,s March 6, ... Foreign Terrorist Entry , refugee vetting can be instilled ... refugee resettlement. (Right now, all refugee applications are ...
Breaking Biology News(10 mins):
(Date:10/12/2017)... (PRWEB) , ... October 12, ... ... today announces publication of a United States multicenter, prospective clinical study that ... disposable, point-of-care diagnostic test capable of identifying clinically significant acute bacterial and ...
(Date:10/11/2017)... (PRWEB) , ... October 11, 2017 , ... ... any gene in its endogenous context, enabling overexpression experiments and avoiding the use ... with small RNA guides is transformative for performing systematic gain-of-function studies. , ...
(Date:10/11/2017)... LAGUNA HILLS, Calif. , Oct. 11, 2017 /PRNewswire/ ... London (ICR) and University of ... tool to risk-stratify patients with multiple myeloma (MM), in a ... . The University of Leeds is ... Myeloma UK, and ICR will perform the testing services to ...
(Date:10/10/2017)... Los Angeles, CA (PRWEB) , ... ... ... Pharmaceuticals, Inc., a development-stage cancer-focused pharmaceutical company advancing targeted antibody-drug conjugate (ADC) ... all uses of targeted HPLN (Hybrid Polymerized Liposomal Nanoparticle), a technology developed ...
Breaking Biology Technology: